Captor Therapeutics ®
News
February 11, 2026
Captor reports: Targeted degradation of GSPT1 in preclinical models of high-risk neuroblastoma
November 28, 2025
NEK7 Kinase: A Breakthrough Target in Inflammation Therapy – Investing in Next-Generation Medicine
November 19, 2025
Captor Therapeutics Enters into a Strategic Agreement with a Pharmaceutical Partner
November 19, 2025
Captor Therapeutics and MD Anderson Cancer Center Sign Research Collaboration Agreement
November 13, 2025
CT-05 The Power of an Antibody in a Tablet
September 25, 2025
Beta-Catenin: An Elusive Target - New Chemistry as a Skeleton Key for Oncological Drugs
September 11, 2025
Captor reports MCL-1 Degraders: What Makes Them a Game-Changer? A New Era in the Fight Against Cancer
August 26, 2025
Captor Therapeutics in Communications Chemistry